Bicycle Therapeutics Press Release. Bcyc a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide bicycle technology today announced that new translational research. We didn t wait for the next advance against cancer.
The trial is. Leone as chief business officer and the promotion of lee kalowski chief financial officer to the role of u s. Bicycle therapeutics is a clinical stage biopharmaceutical company developing a novel class of medicines called bicycles for diseases that are underserved by existing therapeutics.
Bicycles are fully synthetic short peptides constrained to form two loops that stabilize their structural geometry.
Cambridge england boston business wire may 15 2020 bicycle therapeutics plc nasdaq. Legault brings to bicycle more than 35 years of executive leadership experience in the biopharmaceutical industry. View all news news. Cambridge england boston business wire may 15 2020 bicycle therapeutics plc nasdaq.